Free Trial

SeaStar Medical (ICUCW) Competitors

$0.03 +0.00 (+4.17%)
As of 02:13 PM Eastern

ICUCW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying SeaStar Medical stock or one of its competitors? The main competitors of SeaStar Medical include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

SeaStar Medical vs.

180 Life Sciences (NASDAQ:ATNFW) and SeaStar Medical (NASDAQ:ICUCW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, community ranking, earnings and institutional ownership.

In the previous week, 180 Life Sciences' average media sentiment score of 0.59 beat SeaStar Medical's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
SeaStar Medical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
SeaStar Medical$135KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
SeaStar Medical N/A N/A N/A

180 Life Sciences and SeaStar Medical both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
SeaStar MedicalN/AN/A

Summary

180 Life Sciences and SeaStar Medical tied by winning 1 of the 2 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICUCW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUCW vs. The Competition

MetricSeaStar MedicalBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$123.06M$5.46B$7.91B
Dividend YieldN/A3.69%5.37%4.22%
P/E RatioN/A3.2922.7518.78
Price / SalesN/A4,162.22389.32105.05
Price / CashN/A13.0238.2534.62
Price / BookN/A34.006.714.25
Net IncomeN/A-$90.45M$3.23B$247.85M
7 Day PerformanceN/A-0.52%-2.17%0.15%
1 Month PerformanceN/A8.60%8.68%11.15%
1 Year PerformanceN/A92.99%14.77%2.57%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICUCW
SeaStar Medical
N/A$0.03
+4.2%
N/A-64.0%$0.00$135,000.000.0012Gap Up
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-9.9%$0.00N/A0.007Positive News
SXTPW
60 Degrees Pharmaceuticals
N/A$0.06
-0.2%
N/AN/A$0.00$607,574.000.002
DRTSW
Alpha Tau Medical
N/A$0.18
-18.2%
N/A-26.0%$0.00N/A0.0080
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.02
+50.0%
N/A-38.5%$0.00N/A0.0059Positive News
Gap Down
BCTXW
BriaCell Therapeutics
N/A$0.12
+8.0%
N/A-89.0%$0.00N/A0.008Gap Up
CDIOW
Cardio Diagnostics
N/A$0.03
+4.3%
N/A-64.1%$0.00$34,890.000.007Positive News
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-63.4%$0.00$32,839.000.0014Gap Up
CELUW
Celularity
N/A$0.04
-10.1%
N/AN/A$0.00$48.20M0.00220Positive News
Gap Down
CEROW
CERo Therapeutics
N/A$0.02
+21.4%
N/A-81.5%$0.00N/A0.008Gap Up

Related Companies and Tools


This page (NASDAQ:ICUCW) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners